CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $196,000 | -22.2% | 84,091 | -5.1% | 0.00% | 0.0% |
Q4 2017 | $252,000 | +8.6% | 88,614 | +9.2% | 0.00% | 0.0% |
Q3 2017 | $232,000 | +25.4% | 81,138 | +8.1% | 0.00% | 0.0% |
Q2 2017 | $185,000 | -12.7% | 75,072 | +27.6% | 0.00% | 0.0% |
Q1 2017 | $212,000 | +8.7% | 58,838 | +7.1% | 0.00% | 0.0% |
Q4 2016 | $195,000 | -99.9% | 54,958 | -0.3% | 0.00% | 0.0% |
Q3 2016 | $222,604,000 | -7.8% | 55,100 | +0.2% | 0.00% | 0.0% |
Q2 2016 | $241,520,000 | +4.6% | 55,016 | -10.0% | 0.00% | 0.0% |
Q1 2016 | $231,000,000 | -76.0% | 61,125 | -0.3% | 0.00% | -75.0% |
Q4 2015 | $961,000,000 | +151477.3% | 61,325 | +2.1% | 0.00% | +33.3% |
Q3 2015 | $634,000 | -100.0% | 60,088 | -0.3% | 0.00% | -50.0% |
Q2 2015 | $1,519,984,000 | -7.4% | 60,269 | +2.4% | 0.01% | -14.3% |
Q1 2015 | $1,640,791,000 | +54.9% | 58,873 | +1.4% | 0.01% | +40.0% |
Q4 2014 | $1,059,487,000 | +35.4% | 58,054 | -3.8% | 0.01% | +66.7% |
Q3 2014 | $782,486,000 | -19.8% | 60,377 | +0.9% | 0.00% | -25.0% |
Q2 2014 | $976,263,000 | -9.9% | 59,820 | -2.4% | 0.00% | -20.0% |
Q1 2014 | $1,083,400,000 | -25.2% | 61,313 | +2.4% | 0.01% | -28.6% |
Q4 2013 | $1,449,139,000 | -27.0% | 59,857 | +6.8% | 0.01% | -36.4% |
Q3 2013 | $1,985,001,000 | +129.0% | 56,026 | +0.9% | 0.01% | +120.0% |
Q2 2013 | $866,636,000 | – | 55,518 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLP Enterprises, LLC | 6,865,006 | $3,457,000 | 100.00% |
Meditor Group Ltd | 6,312,700 | $3,179,000 | 0.62% |
TSP Capital Management Group, LLC | 1,328,207 | $669,000 | 0.34% |
GREAT POINT PARTNERS LLC | 804,483 | $405,000 | 0.06% |
Telemetry Investments, L.L.C. | 252,300 | $127,000 | 0.05% |
Centiva Capital, LP | 187,749 | $95,000 | 0.02% |
Benchmark Capital Advisors | 54,400 | $27,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 639,800 | $322,000 | 0.02% |
BOENNING & SCATTERGOOD, INC. | 79,400 | $40,000 | 0.01% |
LMR Partners LLP | 408,846 | $206,000 | 0.01% |